BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh R, Ramasubramanian B, Kanji S, Chakraborty AR, Haque SJ, Chakravarti A. Circulating microRNAs in cancer: Hope or hype? Cancer Lett 2016;381:113-21. [PMID: 27471105 DOI: 10.1016/j.canlet.2016.07.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo M, Lian J, Liu Y, Dong B, He Q, Zhao Q, Zhang H, Qi Y, Zhang Y, Huang L. Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma. Biomark Res 2022;10:77. [PMID: 36329557 DOI: 10.1186/s40364-022-00424-x] [Reference Citation Analysis]
2 Mokhtari F, Kaboosi H, Mohebbi SR, Asadzadeh Aghdaei H, Zali MRZ, Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran, Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran, Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Evaluation of Circulating MicroRNA-222 in Patients with Chronic Hepatitis B virus Infection as a Potential Noninvasive Diagnostic Biomarker. Iran J Med Microbiol 2022;16:543-550. [DOI: 10.30699/ijmm.16.6.543] [Reference Citation Analysis]
3 Cheong JK, Rajgor D, Lv Y, Chung KY, Tang YC, Cheng H. Noncoding RNome as Enabling Biomarkers for Precision Health. IJMS 2022;23:10390. [DOI: 10.3390/ijms231810390] [Reference Citation Analysis]
4 Liu Y, Lyu N, Rodger A, Wang Y. Surface-enhanced Raman spectroscopy for circulating biomarkers detection in clinical diagnosis. Principles and Clinical Diagnostic Applications of Surface-Enhanced Raman Spectroscopy 2022. [DOI: 10.1016/b978-0-12-821121-2.00008-1] [Reference Citation Analysis]
5 Tarasiuk A, Mackiewicz T, Małecka-Panas E, Fichna J. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool? Cancer Biol Ther 2021;22:347-56. [PMID: 34224317 DOI: 10.1080/15384047.2021.1941584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Motta F, Pederzani A, Carena MC, Ceribelli A, Wordsworth PB, De Santis M, Selmi C, Vecellio M. MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis. Curr Rheumatol Rep 2021;23:59. [PMID: 34216293 DOI: 10.1007/s11926-021-01027-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tu H, Chang K, Lin S, Hung W, Ji S, Wu H, Liu C. Aberrant miR-10b, miR-372, and miR-375 expression in the cytobrushed samples from oral potentially malignant disorders. Journal of Dental Sciences 2021. [DOI: 10.1016/j.jds.2021.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang J, Han B, Yi Y, Wang Y, Zhang L, Jia H, Lv J, Yang X, Jiang D, Zhang J. Expression profiles and functional analysis of plasma tRNA-derived small RNAs in children with fulminant myocarditis. Epigenomics 2021;13:1057-75. [PMID: 34114472 DOI: 10.2217/epi-2021-0109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Vashisht A, Gahlay GK. Using miRNAs as diagnostic biomarkers for male infertility: opportunities and challenges. Mol Hum Reprod 2020;26:199-214. [PMID: 32084276 DOI: 10.1093/molehr/gaaa016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
10 Sasi S, Singh S, Walia T, Meena RC, Thakur S. Role of MicroRNA In Situ Hybridization in Colon Cancer Diagnosis. Colon Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-3-030-63369-1_5] [Reference Citation Analysis]
11 Peregorodiev IN, Vinokurova SV, Bohyan VY, Delektorskaya VV, Malikhova OA, Gorbunova VA, Sakibov BI, Elkin DS, Stilidi IS. Role of microRNAs in neuroendocrine neoplasms of the stomach. Usp mol onkol 2020;7:19-26. [DOI: 10.17650/2313-805x-2020-7-3-19-26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Li JR, Tong CY, Sung TJ, Kang TY, Zhou XJ, Liu CC. CMEP: a database for circulating microRNA expression profiling. Bioinformatics 2019;35:3127-32. [PMID: 30668638 DOI: 10.1093/bioinformatics/btz042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
13 Huang G, Wei B, Chen Z, Wang J, Zhao L, Peng X, Liu K, Lai Y, Ni L. Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection. Biomarkers in Medicine 2020;14:749-60. [DOI: 10.2217/bmm-2019-0605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Lee BK, Kim MH, Lee SY, Son SJ, Hong CH, Jung YS. Downregulated Platelet miR-1233-5p in Patients with Alzheimer's Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin. J Clin Med 2020;9:E1642. [PMID: 32485903 DOI: 10.3390/jcm9061642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Xu X, Xia Y, Ma J, Li W, Niu N, Li X, Tao H, Xu J, He X. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling. Int J Oncol 2020;57:522-32. [PMID: 32468020 DOI: 10.3892/ijo.2020.5072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Jamali Z, Taheri-Anganeh M, Shabaninejad Z, Keshavarzi A, Taghizadeh H, Razavi ZS, Mottaghi R, Abolhassan M, Movahedpour A, Mirzaei H. Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy. IUBMB Life 2020;72:1306-21. [PMID: 32233112 DOI: 10.1002/iub.2277] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis]
17 Lai Z, Cao Y. Plasma miR-200c-3p, miR-100-5p, and miR-1826 serve as potential diagnostic biomarkers for knee osteoarthritis: Randomized controlled trials. Medicine (Baltimore) 2019;98:e18110. [PMID: 31860959 DOI: 10.1097/MD.0000000000018110] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
18 Yin X, Zheng X, Liu M, Wang D, Sun H, Qiu Y, Chen J, Shi B. Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells. Cell Biol Int 2020;44:958-65. [PMID: 31872468 DOI: 10.1002/cbin.11292] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
19 Dini P, El-Sheikh Ali H, Carossino M, C Loux S, Esteller-Vico A, E Scoggin K, Daels P, A Ball B. Expression Profile of the Chromosome 14 MicroRNA Cluster (C14MC) Ortholog in Equine Maternal Circulation throughout Pregnancy and Its Potential Implications. Int J Mol Sci 2019;20:E6285. [PMID: 31847075 DOI: 10.3390/ijms20246285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Loke SY, Munusamy P, Koh GL, Chan CHT, Madhukumar P, Thung JL, Tan KTB, Ong KW, Yong WS, Sim Y, Oey CL, Lim SZ, Chan MYP, Ho TSJ, Khoo BKJ, Wong SLJ, Thng CH, Chong BK, Tan EY, Tan VK, Lee ASG. A Circulating miRNA Signature for Stratification of Breast Lesions among Women with Abnormal Screening Mammograms. Cancers (Basel) 2019;11:E1872. [PMID: 31769433 DOI: 10.3390/cancers11121872] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
21 Rapado-González Ó, Majem B, Álvarez-Castro A, Díaz-Peña R, Abalo A, Suárez-Cabrera L, Gil-Moreno A, Santamaría A, López-López R, Muinelo-Romay L, Suarez-Cunqueiro MM. A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis. J Clin Med 2019;8:E2029. [PMID: 31757017 DOI: 10.3390/jcm8122029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
22 Bottani M, Banfi G, Lombardi G. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma. J Clin Med 2019;8:E1661. [PMID: 31614612 DOI: 10.3390/jcm8101661] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
23 Salvianti F, Gelmini S, Costanza F, Mancini I, Sonnati G, Simi L, Pazzagli M, Pinzani P. The pre-analytical phase of the liquid biopsy. N Biotechnol 2020;55:19-29. [PMID: 31580920 DOI: 10.1016/j.nbt.2019.09.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
24 Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R, Zhang X. Circulating MicroRNAs in Cancer: Potential and Challenge. Front Genet 2019;10:626. [PMID: 31379918 DOI: 10.3389/fgene.2019.00626] [Cited by in Crossref: 181] [Cited by in F6Publishing: 199] [Article Influence: 60.3] [Reference Citation Analysis]
25 Grimaldi AM, Incoronato M. Clinical Translatability of "Identified" Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update. Cancers (Basel) 2019;11:E901. [PMID: 31252695 DOI: 10.3390/cancers11070901] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
26 Rezayi M, Farjami Z, Hosseini ZS, Ebrahimi N, Abouzari-lotf E. MicroRNA-based Biosensors for Early Detection of Cancers. CPD 2019;24:4675-80. [DOI: 10.2174/1381612825666190111144525] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
27 Filipów S, Łaczmański Ł. Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response. Front Genet 2019;10:169. [PMID: 30915102 DOI: 10.3389/fgene.2019.00169] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 19.0] [Reference Citation Analysis]
28 Saliminejad K, Khorram Khorshid HR, Ghaffari SH. Why have microRNA biomarkers not been translated from bench to clinic? Future Oncology 2019;15:801-3. [DOI: 10.2217/fon-2018-0812] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
29 Masud MK, Umer M, Hossain MSA, Yamauchi Y, Nguyen NT, Shiddiky MJA. Nanoarchitecture Frameworks for Electrochemical miRNA Detection. Trends Biochem Sci 2019;44:433-52. [PMID: 30686572 DOI: 10.1016/j.tibs.2018.11.012] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 26.3] [Reference Citation Analysis]
30 Wang N, Guo H, Dong Z, Chen Q, Zhang X, Shen W, Bao Y, Wang X. Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer. Cancer Manag Res 2018;10:3463-71. [PMID: 30254489 DOI: 10.2147/CMAR.S170481] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
31 Mithraprabhu S, Spencer A. Liquid Biopsy in Multiple Myeloma. In: Guenova M, Balatzenko G, editors. Hematology - Latest Research and Clinical Advances. InTech; 2018. [DOI: 10.5772/intechopen.72652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Tinay I, Tan M, Gui B, Werner L, Kibel AS, Jia L. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. Prostate 2018;78:927-37. [PMID: 29748958 DOI: 10.1002/pros.23650] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
33 Mumford SL, Towler BP, Pashler AL, Gilleard O, Martin Y, Newbury SF. Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine. Biomolecules. 2018;8:21. [PMID: 29701682 DOI: 10.3390/biom8020021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 11.5] [Reference Citation Analysis]
34 Malczewska A, Kidd M, Matar S, Kos-Kudla B, Modlin IM. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 2018;107:73-90. [PMID: 29566385 DOI: 10.1159/000487326] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
35 Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H, Zhu W, Ding Q, Wang S. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Breast Cancer Res Treat 2018;170:257-70. [PMID: 29557526 DOI: 10.1007/s10549-018-4757-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 17.3] [Reference Citation Analysis]
36 Ali MA, Matboli M, El-Khazragy N, Saber O, El-Nakeep S, Abdelzaher HM, Shafei AE, Mostafa R. Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma. Biomark Med 2018;12:245-56. [PMID: 29441798 DOI: 10.2217/bmm-2017-0273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
37 Lee H, Lee SM. Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer. Korean J Helicobacter Up Gastrointest Res 2018;18:168. [DOI: 10.7704/kjhugr.2018.18.3.168] [Reference Citation Analysis]
38 Ciniselli CM, Lecchi M, Gariboldi M, Verderio P, Daidone MG. Workflow for Circulating miRNA Identification and Development in Cancer Research: Methodological Considerations. Precision Medicine 2018. [DOI: 10.1016/b978-0-12-805364-5.00006-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Luo J, Wang Z, Huang J, Yao Y, Sun Q, Wang J, Shen Y, Xu L, Ren B. HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3. Cancer Sci 2018;109:317-29. [PMID: 29168599 DOI: 10.1111/cas.13453] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
40 Modlin IM, Kidd M, Filosso PL, Roffinella M, Lewczuk A, Cwikla J, Bodei L, Kolasinska-Cwikla A, Chung KM, Tesselaar ME, Drozdov IA. Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms. J Thorac Dis 2017;9:S1458-73. [PMID: 29201449 DOI: 10.21037/jtd.2017.03.82] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
41 Smolle MA, Leithner A, Posch F, Szkandera J, Liegl-Atzwanger B, Pichler M. MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review. Int J Mol Sci 2017;18:E1960. [PMID: 28895916 DOI: 10.3390/ijms18091960] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
42 Chen YX, Huang KJ, Niu KX. Recent advances in signal amplification strategy based on oligonucleotide and nanomaterials for microRNA detection-a review. Biosens Bioelectron 2018;99:612-24. [PMID: 28837925 DOI: 10.1016/j.bios.2017.08.036] [Cited by in Crossref: 165] [Cited by in F6Publishing: 151] [Article Influence: 33.0] [Reference Citation Analysis]
43 Zhong L, Sun S, Shi J, Cao F, Han X, Chen Z. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3. Tumour Biol 2017;39:1010428317697579. [PMID: 28631574 DOI: 10.1177/1010428317697579] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
44 Beyer S, Fleming J, Meng W, Singh R, Haque SJ, Chakravarti A. The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas. Cancers (Basel) 2017;9:E85. [PMID: 28698530 DOI: 10.3390/cancers9070085] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
45 Chen W, Liu Y, Chen H, Ning H, Ding K. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis. Int J Oncol 2017;51:435-44. [PMID: 28627667 DOI: 10.3892/ijo.2017.4038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
46 Islam MN, Masud MK, Haque MH, Hossain MSA, Yamauchi Y, Nguyen N, Shiddiky MJA. RNA Biomarkers: Diagnostic and Prognostic Potentials and Recent Developments of Electrochemical Biosensors. Small Methods 2017;1:1700131. [DOI: 10.1002/smtd.201700131] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 13.2] [Reference Citation Analysis]
47 Mari-Alexandre J, Diaz-Lagares A, Villalba M, Juan O, Crujeiras AB, Calvo A, Sandoval J. Translating cancer epigenomics into the clinic: focus on lung cancer. Transl Res 2017;189:76-92. [PMID: 28644958 DOI: 10.1016/j.trsl.2017.05.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
48 Lin CE, Kaptein JS, Sheikh J. Differential expression of microRNAs and their possible roles in patients with chronic idiopathic urticaria and active hives. Allergy Rhinol (Providence) 2017;8:67-80. [PMID: 28583230 DOI: 10.2500/ar.2017.8.0199] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
49 Xu Z, Xi T, Han Y, Guo X, Liu F, Jiang M, Wan D, Xue X, He S, Ren R, Li W, Zhi Q. Circulating miR-1826 in plasma correlates with circulating tumor cells and is a prognostic marker in colorectal cancer. Tumour Biol 2017;39:1010428317705333. [PMID: 28468583 DOI: 10.1177/1010428317705333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Li Z, Jiang J, Tian L, Li X, Chen J, Li S, Li C, Yang Z. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs. PLoS One 2017;12:e0175407. [PMID: 28467514 DOI: 10.1371/journal.pone.0175407] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
51 Loux SC, Scoggin KE, Bruemmer JE, Canisso IF, Troedsson MH, Squires EL, Ball BA. Evaluation of circulating miRNAs during late pregnancy in the mare. PLoS One 2017;12:e0175045. [PMID: 28388652 DOI: 10.1371/journal.pone.0175045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
52 Ji W, Sun B, Su C. Targeting MicroRNAs in Cancer Gene Therapy. Genes (Basel). 2017;8:21. [PMID: 28075356 DOI: 10.3390/genes8010021] [Cited by in Crossref: 104] [Cited by in F6Publishing: 117] [Article Influence: 20.8] [Reference Citation Analysis]
53 Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao H, Teschendorff AE. dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers. Nucleic Acids Res 2017;45:D812-8. [PMID: 27899556 DOI: 10.1093/nar/gkw1079] [Cited by in Crossref: 211] [Cited by in F6Publishing: 224] [Article Influence: 35.2] [Reference Citation Analysis]